August 9, 2024 – We are very excited to announce that Divergence Neuro Technologies Inc. has partnered with Clinicom to bring their augmented intelligence-based assessment tool to Divergence customers!

This partnership will allow us to offer a validated adaptive assessment tool that can help clinicians monitor over 80 DSM conditions fully online. The tool uses augmented intelligence with over 250 clinically validated algorithms to gather bio-psycho-social information to produce turnkey patient reports that provide insights and can guide diagnosis.

“Clinicom’s numbers speak for themselves. With nearly 95% completion rates with no human intervention required, more than 90% of patients say the tool is easy to use and over 80% increased identification of hidden comorbidities, the Clinicom adaptive assessment is a must have for clinicians!” said Alex Ni, CEO of Divergence. “We are truly honoured to partner with Clinicom and to bring their 20 years of expertise in developing and delivering rigorously validated assessments to our clinical customers.”